Is Ranibizumab Superior to Laser for DME?
November 15, 2009
The end of laser for diabetic macular edema? I think so. A six month trial published in Ophthalmology comparing ranibizumab to laser showed clear superiority (not even close) to focal/grid for diabetic macular edema. I honestly think I will start to offer this to my patients as first line treatment- I hate the laser’s destructive properties, especially when the edema is so close to the fovea.
Comments
Jump down to form below to submit your own comments
2 Responses to “Is Ranibizumab Superior to Laser for DME?”
I share your optimism.
It is not clear in whom or how often we should be giving these injections, but there is tremendous interest in the “retina” world for anti-VEGF and diabetic macular edema.
Long-acting sustained release technology is next!!
but cost-effectiveness?
